FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890934250> ?p ?o ?g. }

• W2890934250 endingPage "373" @default.
• W2890934250 startingPage "363" @default.
• W2890934250 abstract "Purpose To determine predictors and outcomes for oral squamous cell carcinoma (OSCC) patients who had early recurrence before commencement of postoperative radiation therapy (PORT). Methods Retrospective review was performed for patients with OSCC treated with PORT between 2003 and 2015 after curative-intent surgery. Early recurrence was defined as tumor recurrence after surgical resection and before initiating planned PORT. Patients were classified into the following groups: (1) adjuvant PORT group (no early recurrence), (2) salvage PORT group (locoregional early recurrence), and (3) palliative PORT group (locoregional and distant early recurrence). For the whole cohort, multivariable analysis (MVA) was applied to identify predictors of early recurrence. In the salvage group, the post-PORT recurrence-free rate was estimated, and MVA was used to identify predictors of recurrence-free rate, disease-free survival, and overall survival (OS). Results Six hundred and one patients were identified, of whom 513 (85%) were treated with adjuvant PORT. Eighty-eight patients (15%) had early recurrence (28 of 88; 32% were biopsy proven) before PORT (70 in the salvage group and 18 in the palliative group). On MVA, oral tongue subsite, microscopic positive resection margin, pT3-4, and pN2-3 were associated with the development of early recurrence (P < .05 for all). The 3-year OS rates for patients with OSCC treated with adjuvant and salvage PORT were 71% (95% confidence interval [CI], 67%-75%) and 41% (95% CI, 30%-56%), respectively (P < .001; median follow-up was 3.4 and 2.9 years, respectively). After salvage PORT, the 3-year recurrence-free rate was 36% (95% CI, 23%-47%). On MVA, extranodal extension and volume of early recurrent gross disease were associated with poor recurrence-free rate, disease-free survival, and OS (P < .05 for all). Conclusion Early recurrences are not uncommon in patients with high-risk features, Further study is required to improve prediction and outcomes of this very high-risk group. To determine predictors and outcomes for oral squamous cell carcinoma (OSCC) patients who had early recurrence before commencement of postoperative radiation therapy (PORT). Retrospective review was performed for patients with OSCC treated with PORT between 2003 and 2015 after curative-intent surgery. Early recurrence was defined as tumor recurrence after surgical resection and before initiating planned PORT. Patients were classified into the following groups: (1) adjuvant PORT group (no early recurrence), (2) salvage PORT group (locoregional early recurrence), and (3) palliative PORT group (locoregional and distant early recurrence). For the whole cohort, multivariable analysis (MVA) was applied to identify predictors of early recurrence. In the salvage group, the post-PORT recurrence-free rate was estimated, and MVA was used to identify predictors of recurrence-free rate, disease-free survival, and overall survival (OS). Six hundred and one patients were identified, of whom 513 (85%) were treated with adjuvant PORT. Eighty-eight patients (15%) had early recurrence (28 of 88; 32% were biopsy proven) before PORT (70 in the salvage group and 18 in the palliative group). On MVA, oral tongue subsite, microscopic positive resection margin, pT3-4, and pN2-3 were associated with the development of early recurrence (P < .05 for all). The 3-year OS rates for patients with OSCC treated with adjuvant and salvage PORT were 71% (95% confidence interval [CI], 67%-75%) and 41% (95% CI, 30%-56%), respectively (P < .001; median follow-up was 3.4 and 2.9 years, respectively). After salvage PORT, the 3-year recurrence-free rate was 36% (95% CI, 23%-47%). On MVA, extranodal extension and volume of early recurrent gross disease were associated with poor recurrence-free rate, disease-free survival, and OS (P < .05 for all). Early recurrences are not uncommon in patients with high-risk features, Further study is required to improve prediction and outcomes of this very high-risk group." @default.
• W2890934250 created "2018-09-27" @default.
• W2890934250 creator A5010067099 @default.
• W2890934250 creator A5032324904 @default.
• W2890934250 creator A5034034839 @default.
• W2890934250 creator A5034148230 @default.
• W2890934250 creator A5034164067 @default.
• W2890934250 creator A5037725319 @default.
• W2890934250 creator A5037763217 @default.
• W2890934250 creator A5044565573 @default.
• W2890934250 creator A5046679576 @default.
• W2890934250 creator A5047110724 @default.
• W2890934250 creator A5048005267 @default.
• W2890934250 creator A5052721859 @default.
• W2890934250 creator A5059043243 @default.
• W2890934250 creator A5063842271 @default.
• W2890934250 creator A5078390519 @default.
• W2890934250 creator A5081648155 @default.
• W2890934250 creator A5084323572 @default.
• W2890934250 creator A5084339717 @default.
• W2890934250 creator A5085913057 @default.
• W2890934250 creator A5088186975 @default.
• W2890934250 creator A5090412207 @default.
• W2890934250 date "2019-02-01" @default.
• W2890934250 modified "2023-10-16" @default.
• W2890934250 title "Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy" @default.
• W2890934250 cites W1593348144 @default.
• W2890934250 cites W1774738402 @default.
• W2890934250 cites W1993295404 @default.
• W2890934250 cites W1995321234 @default.
• W2890934250 cites W2016590985 @default.
• W2890934250 cites W2022775755 @default.
• W2890934250 cites W2025557698 @default.
• W2890934250 cites W2026164711 @default.
• W2890934250 cites W2040549950 @default.
• W2890934250 cites W2051704910 @default.
• W2890934250 cites W2056111356 @default.
• W2890934250 cites W2061767333 @default.
• W2890934250 cites W2069355079 @default.
• W2890934250 cites W2077748641 @default.
• W2890934250 cites W2090293084 @default.
• W2890934250 cites W2090468974 @default.
• W2890934250 cites W2120068217 @default.
• W2890934250 cites W2121398513 @default.
• W2890934250 cites W2123027910 @default.
• W2890934250 cites W2127903844 @default.
• W2890934250 cites W2131625550 @default.
• W2890934250 cites W2142222095 @default.
• W2890934250 cites W2143161736 @default.
• W2890934250 cites W2143454041 @default.
• W2890934250 cites W2145078756 @default.
• W2890934250 cites W2159631730 @default.
• W2890934250 cites W2165802395 @default.
• W2890934250 cites W2185147575 @default.
• W2890934250 cites W2235523093 @default.
• W2890934250 cites W2359365408 @default.
• W2890934250 cites W2562953532 @default.
• W2890934250 cites W2563241616 @default.
• W2890934250 cites W2728163960 @default.
• W2890934250 cites W2748605114 @default.
• W2890934250 cites W2797662536 @default.
• W2890934250 cites W2917837889 @default.
• W2890934250 doi "https://doi.org/10.1016/j.ijrobp.2018.09.013" @default.
• W2890934250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30244160" @default.
• W2890934250 hasPublicationYear "2019" @default.
• W2890934250 type Work @default.
• W2890934250 sameAs 2890934250 @default.
• W2890934250 citedByCount "35" @default.
• W2890934250 countsByYear W28909342502019 @default.
• W2890934250 countsByYear W28909342502020 @default.
• W2890934250 countsByYear W28909342502021 @default.
• W2890934250 countsByYear W28909342502022 @default.
• W2890934250 countsByYear W28909342502023 @default.
• W2890934250 crossrefType "journal-article" @default.
• W2890934250 hasAuthorship W2890934250A5010067099 @default.
• W2890934250 hasAuthorship W2890934250A5032324904 @default.
• W2890934250 hasAuthorship W2890934250A5034034839 @default.
• W2890934250 hasAuthorship W2890934250A5034148230 @default.
• W2890934250 hasAuthorship W2890934250A5034164067 @default.
• W2890934250 hasAuthorship W2890934250A5037725319 @default.
• W2890934250 hasAuthorship W2890934250A5037763217 @default.
• W2890934250 hasAuthorship W2890934250A5044565573 @default.
• W2890934250 hasAuthorship W2890934250A5046679576 @default.
• W2890934250 hasAuthorship W2890934250A5047110724 @default.
• W2890934250 hasAuthorship W2890934250A5048005267 @default.
• W2890934250 hasAuthorship W2890934250A5052721859 @default.
• W2890934250 hasAuthorship W2890934250A5059043243 @default.
• W2890934250 hasAuthorship W2890934250A5063842271 @default.
• W2890934250 hasAuthorship W2890934250A5078390519 @default.
• W2890934250 hasAuthorship W2890934250A5081648155 @default.
• W2890934250 hasAuthorship W2890934250A5084323572 @default.
• W2890934250 hasAuthorship W2890934250A5084339717 @default.
• W2890934250 hasAuthorship W2890934250A5085913057 @default.
• W2890934250 hasAuthorship W2890934250A5088186975 @default.
• W2890934250 hasAuthorship W2890934250A5090412207 @default.
• W2890934250 hasConcept C119599485 @default.
• W2890934250 hasConcept C126322002 @default.
• W2890934250 hasConcept C127413603 @default.

• next